{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:20:17Z","timestamp":1781896817350,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1053\/j.ajkd.2023.06.005","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T04:00:58Z","timestamp":1695182458000},"page":"79-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease"],"prefix":"10.1053","volume":"83","author":[{"given":"Halimat","family":"Afolabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing M.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"O\u2019Shaughnessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lafayette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Charu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1053\/j.ajkd.2023.06.005_bib1","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMra1108178","article-title":"Membranoproliferative glomerulonephritis\u2014a new look at an old entity","volume":"366","author":"Sethi","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2023.06.005_bib2","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00467-009-1322-7","article-title":"Membranoproliferative glomerulonephritis","volume":"25","author":"Alchi","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.06.005_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semnephrol.2011.06.005","article-title":"Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification","volume":"31","author":"Sethi","year":"2011","journal-title":"Semin Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.06.005_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1681\/ASN.2019040433","article-title":"Large-scale whole-genome sequencing reveals the genetic architecture of primary membranoproliferative GN and C3 glomerulopathy","volume":"31","author":"Levine","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4 suppl 1","key":"10.1053\/j.ajkd.2023.06.005_bib5","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US Renal Data System 2020 annual data report: epidemiology of kidney disease in the United States","volume":"77","author":"Johansen","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2023.06.005_bib6","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1046\/j.1523-1755.1999.00720.x","article-title":"The HLA complex in Goodpasture\u2019s disease: a model for analyzing susceptibility to autoimmunity","volume":"56","author":"Phelps","year":"1999","journal-title":"Kidney Int"},{"issue":"8071","key":"10.1053\/j.ajkd.2023.06.005_bib7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(78)90252-0","article-title":"Strong association between HLA-DRW2 and antibody-mediated Goodpasture\u2019s syndrome","volume":"1","author":"Rees","year":"1978","journal-title":"Lancet"},{"issue":"4","key":"10.1053\/j.ajkd.2023.06.005_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ki.1984.194","article-title":"The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritis","volume":"26","author":"Rees","year":"1984","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2023.06.005_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ki.1993.245","article-title":"Associations of HLA-DR and HLA-DQ types with anti-GBM nephritis by sequence-specific oligonucleotide probe hybridization","volume":"44","author":"Huey","year":"1993","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2023.06.005_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ki.1997.27","article-title":"Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes","volume":"51","author":"Fisher","year":"1997","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2023.06.005_bib11","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1093\/ndt\/gfn179","article-title":"The HLA-DRB1\u22171501 allele is prevalent among Japanese patients with anti-glomerular basement membrane antibody-mediated disease","volume":"23","author":"Kitagawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2023.06.005_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clim.2009.07.005","article-title":"The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease","volume":"133","author":"Yang","year":"2009","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1053\/j.ajkd.2023.06.005_bib13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0198-8859(01)00298-1","article-title":"Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations","volume":"62","author":"Cao","year":"2001","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.06.005_bib14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2023.06.005_bib15","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Web site and R package for computing E-values","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"issue":"10","key":"10.1053\/j.ajkd.2023.06.005_bib16","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41581-018-0057-8","article-title":"HLA and kidney disease: from associations to mechanisms","volume":"14","author":"Robson","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2023.06.005_bib17","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1007\/s00125-012-2608-z","article-title":"Use of class I and class II HLA loci for predicting age at onset of type 1 diabetes in multiple populations","volume":"55","author":"Valdes","year":"2012","journal-title":"Diabetologia"},{"issue":"10","key":"10.1053\/j.ajkd.2023.06.005_bib18","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1681\/ASN.2010010076","article-title":"HLA has strongest association with IgA nephropathy in genome-wide analysis","volume":"21","author":"Feehally","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2023.06.005_bib19","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1681\/ASN.2016121331","article-title":"Association analysis of the MHC in lupus nephritis","volume":"28","author":"Xu","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.06.005_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ndt\/gfw001","article-title":"Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies","volume":"32","author":"Sekula","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2023.06.005_bib21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00467-011-2059-7","article-title":"Clinical features and outcomes of 98 children and adults with dense deposit disease","volume":"27","author":"Lu","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.06.005_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0090-1229(78)90004-1","article-title":"HLA antigen in three types of glomerulonephritis","volume":"10","author":"No\u00ebl","year":"1978","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.06.005_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/iji.12566","article-title":"Systematic review of associations between HLA and renal function","volume":"49","author":"Lowe","year":"2022","journal-title":"Int J Immunogenet"},{"key":"10.1053\/j.ajkd.2023.06.005_bib24","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14792","article-title":"Association between human leukocyte antigen (HLA) and end-stage renal disease (ESRD): a meta-analysis","volume":"11","author":"Noureen","year":"2023","journal-title":"PeerJ"},{"issue":"2","key":"10.1053\/j.ajkd.2023.06.005_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014643","article-title":"HLA DNA sequence variation among human populations: molecular signatures of demographic and selective events","volume":"6","author":"Buhler","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.ajkd.2023.06.005_bib26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1399-0039.1996.tb02686.x","article-title":"African-American HLA class II allele and haplotype diversity","volume":"48","author":"Just","year":"1996","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1053\/j.ajkd.2023.06.005_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1399-0039.2006.00728.x","article-title":"HLA-A, -B, -C, -DRB1 allele and haplotype frequencies in an African American population","volume":"69","author":"Tu","year":"2007","journal-title":"Tissue Antigens"}],"updated-by":[{"DOI":"10.1053\/j.ajkd.2026.04.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623007977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623007977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:35:24Z","timestamp":1780670124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638623007977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0272638623007977"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.06.005","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}